{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:10:02Z","timestamp":1748833802458,"version":"3.41.0"},"reference-count":53,"publisher":"Informa UK Limited","issue":"6","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ricerca Corrente 2025"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Anticancer Therapy"],"published-print":{"date-parts":[[2025,6,3]]},"DOI":"10.1080\/14737140.2025.2492787","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T10:07:11Z","timestamp":1745057231000},"page":"609-619","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["An evaluation of epcoritamab as a treatment for relapsed or refractory follicular lymphoma"],"prefix":"10.1080","volume":"25","author":[{"given":"Francesca","family":"Bonello","sequence":"first","affiliation":[{"name":"FPO-IRCCS","place":["Candiolo (Torino), Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pio Manlio Mirko","family":"Frascione","sequence":"additional","affiliation":[{"name":"FPO-IRCCS","place":["Candiolo (Torino), Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danilo","family":"Faraci","sequence":"additional","affiliation":[{"name":"FPO-IRCCS","place":["Candiolo (Torino), Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umberto","family":"Vitolo","sequence":"additional","affiliation":[{"name":"FPO-IRCCS","place":["Candiolo (Torino), Italy"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"e_1_3_5_3_1","unstructured":"Swerdlow SH Cehnjepssht J. WHO classification of tumours of haematopoietic and lymphoid tissues. 2017."},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.3960\/JSLRT.56.1"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA1614598"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANNONC.2020.11.008"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.00605"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.0866"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01073"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)62175-7"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01234"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000919"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/ANNONC\/MDX496"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.00843"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.02327"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70027-0"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.RADONC.2011.05.013"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.ANNONC.2023.10.095"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2021006240"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-021-01622-0"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00591-X"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00521-4"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/S40265-023-01930-4"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41408-021-00430-6"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.EBIOM.2019.102625"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JIM.2012.11.007"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2003-02-0361"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00889-8"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00166-2"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2024-200262"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.HS9.0000967800.55471.36"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.16_SUPPL.7506"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00010"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2023-180092"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2024.42.16_SUPPL.TPS7084"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1186\/S12885-024-12112-0"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1182\/HEMATOLOGY.2023000438"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1182\/HEMATOLOGY.2023000508"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01725"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41375-024-02410-8"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2024-200369"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/S12185-024-03833-W"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(22)00335-7"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD-2024-197897"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(22)00072-2"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2342"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.2023021243"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOOD.2023021567"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/S41591-024-02986-9"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.00775"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30441-1"},{"key":"e_1_3_5_52_1","volume-title":"Abstract S233 presented at the European Hematology Association 2024 congress","author":"Assouline S","year":"2024","unstructured":"Assouline S, Bartlett NL, Matasar M, et al. Mosunetuzumab demonstrates clinically meaningful outcomes in high-risk patients with heavily pre-treated R\/R FL after \u22653 years of follow-up: subgroup analysis of a pivotal phase II study. In: Abstract S233 presented at the European Hematology Association 2024 congress. Madrid: Spain; 2024 Jun 14."},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.3324\/HAEMATOL.2024.285245"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.JTCT.2024.06.016"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/BLOODADVANCES.2022008097"}],"container-title":["Expert Review of Anticancer Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14737140.2025.2492787","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T02:57:15Z","timestamp":1748833035000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14737140.2025.2492787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,3]]}},"alternative-id":["10.1080\/14737140.2025.2492787"],"URL":"https:\/\/doi.org\/10.1080\/14737140.2025.2492787","relation":{},"ISSN":["1473-7140","1744-8328"],"issn-type":[{"type":"print","value":"1473-7140"},{"type":"electronic","value":"1744-8328"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iery20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-01-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}